share_log

新銳醫藥：股東週年大會通告

NEW RAY MEDIC: NOTICE OF ANNUAL GENERAL MEETING

Hong Kong Stock Exchange ·  Apr 24 08:36
Summary by Moomoo AI
新銳醫藥國際控股有限公司（「新锐医药」）將於2024年6月18日舉行股東週年大會，地點為香港中環德輔道中19號環球大廈。會議議程包括審視及批准截至2023年12月31日止年度的經審核綜合財務報表、董事會報告及核數師報告。此外，會上將進行董事的重選，包括王秋勤女士、褚雪平先生及梁志堅先生，並授權董事會釐定董事酬金。大會還將續聘大華馬施雲會計師事務所為下一財年的核數師並授權董事會釐定其酬金。股東將投票決定是否授權公司在特定條件下發行、配發及處置股份，以及購回不超過已發行股份10%的股份。股東出席大會的資格將根據2024年6月12日的股份過戶登記來確定。
新銳醫藥國際控股有限公司（「新锐医药」）將於2024年6月18日舉行股東週年大會，地點為香港中環德輔道中19號環球大廈。會議議程包括審視及批准截至2023年12月31日止年度的經審核綜合財務報表、董事會報告及核數師報告。此外，會上將進行董事的重選，包括王秋勤女士、褚雪平先生及梁志堅先生，並授權董事會釐定董事酬金。大會還將續聘大華馬施雲會計師事務所為下一財年的核數師並授權董事會釐定其酬金。股東將投票決定是否授權公司在特定條件下發行、配發及處置股份，以及購回不超過已發行股份10%的股份。股東出席大會的資格將根據2024年6月12日的股份過戶登記來確定。
New Sharp Pharmaceuticals International Holdings Limited (“New Sharp Pharmaceuticals”) will hold its Annual General Meeting on 18 June 2024 at the Global Building, 19 Des Voeux Road Central, Hong Kong. The agenda of the meeting includes the review and approval of the audited consolidated financial statements, the Board's reports and the auditor's report for the year ended 31 December 2023. In addition, the Board will re-elect directors, including Ms. Wang Qiu Qin, Mr. Xue Ping and Mr. Leung Chi Kin, and will authorize the Board to determine the directors' remuneration. The General Meeting will also renew the appointment of Dawa Maschuyun Accounting Firm as auditor for the next fiscal year and authorize the Board of Directors to determine his remuneration. Shareholders will vote on whether to authorize the Company to issue, distribute and dispose of shares under certain conditions and to repurchase shares not exceeding 10% of the issued shares. The eligibility of the shareholders to attend the general meeting will be determined on the basis of the share register on June 12, 2024.
New Sharp Pharmaceuticals International Holdings Limited (“New Sharp Pharmaceuticals”) will hold its Annual General Meeting on 18 June 2024 at the Global Building, 19 Des Voeux Road Central, Hong Kong. The agenda of the meeting includes the review and approval of the audited consolidated financial statements, the Board's reports and the auditor's report for the year ended 31 December 2023. In addition, the Board will re-elect directors, including Ms. Wang Qiu Qin, Mr. Xue Ping and Mr. Leung Chi Kin, and will authorize the Board to determine the directors' remuneration. The General Meeting will also renew the appointment of Dawa Maschuyun Accounting Firm as auditor for the next fiscal year and authorize the Board of Directors to determine his remuneration. Shareholders will vote on whether to authorize the Company to issue, distribute and dispose of shares under certain conditions and to repurchase shares not exceeding 10% of the issued shares. The eligibility of the shareholders to attend the general meeting will be determined on the basis of the share register on June 12, 2024.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more